← Open Payments lookup

CHANDLER THIBODAUX: Open Payments

NPI 1205974045 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,934 in 130 payments from 19 companies in 2025. Trend: 2023 $2,847 · 2024 $2,665 · 2025 $2,934

Food & beverage: $2,934
CompanyPaymentsAmount
GENZYME CORPORATION14$604
Regeneron Healthcare Solutions, Inc.16$466
UCB, Inc.22$304
Galderma Laboratories, L.P.10$231
SUN PHARMACEUTICAL INDUSTRIES INC.9$222
Arcutis Biotherapeutics, Inc.15$219
Novartis Pharmaceuticals Corporation8$194
LEO Pharma Inc.7$145
Amgen Inc.5$114
ABBVIE INC.5$96

Products named: DUPIXENT, Bimzelx, NEMLUVIO, Zoryve, ILUMYA, ANZUPGO, OTEZLA, COSENTYX.

Industry payments across TX — which companies pay providers there.